Global Dystrophin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Dystrophin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Dystrophin report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Dystrophin market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Genetic Disorders and Musculoskeletal Disorders are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Dystrophin industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Dystrophin key manufacturers include Asklepios BioPharmaceutical Inc, BioMarin Pharmaceutical Inc, Daiichi Sankyo Company Ltd, Editas Medicine Inc, Genethon SA, Nippon Shinyaku Co Ltd, Pfizer Inc, Sarepta Therapeutics Inc and WAVE Life Sciences Ltd, etc. Asklepios BioPharmaceutical Inc, BioMarin Pharmaceutical Inc, Daiichi Sankyo Company Ltd are top 3 players and held % sales share in total in 2022.
Dystrophin can be divided into DS-5141, Biostrophin, BMBD-001 and NS-065, etc. DS-5141 is the mainstream product in the market, accounting for % sales share globally in 2022.
Dystrophin is widely used in various fields, such as Genetic Disorders, Musculoskeletal Disorders and Others,, etc. Genetic Disorders provides greatest supports to the Dystrophin industry development. In 2022, global % sales of Dystrophin went into Genetic Disorders filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Dystrophin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Asklepios BioPharmaceutical Inc
BioMarin Pharmaceutical Inc
Daiichi Sankyo Company Ltd
Editas Medicine Inc
Genethon SA
Nippon Shinyaku Co Ltd
Pfizer Inc
Sarepta Therapeutics Inc
WAVE Life Sciences Ltd
Segment by Type
DS-5141
Biostrophin
BMBD-001
NS-065
Others
Genetic Disorders
Musculoskeletal Disorders
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Dystrophin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Dystrophin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Dystrophin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Dystrophin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Dystrophin introduction, etc. Dystrophin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Dystrophin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Dystrophin industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Dystrophin key manufacturers include Asklepios BioPharmaceutical Inc, BioMarin Pharmaceutical Inc, Daiichi Sankyo Company Ltd, Editas Medicine Inc, Genethon SA, Nippon Shinyaku Co Ltd, Pfizer Inc, Sarepta Therapeutics Inc and WAVE Life Sciences Ltd, etc. Asklepios BioPharmaceutical Inc, BioMarin Pharmaceutical Inc, Daiichi Sankyo Company Ltd are top 3 players and held % sales share in total in 2022.
Dystrophin can be divided into DS-5141, Biostrophin, BMBD-001 and NS-065, etc. DS-5141 is the mainstream product in the market, accounting for % sales share globally in 2022.
Dystrophin is widely used in various fields, such as Genetic Disorders, Musculoskeletal Disorders and Others,, etc. Genetic Disorders provides greatest supports to the Dystrophin industry development. In 2022, global % sales of Dystrophin went into Genetic Disorders filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Dystrophin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Asklepios BioPharmaceutical Inc
BioMarin Pharmaceutical Inc
Daiichi Sankyo Company Ltd
Editas Medicine Inc
Genethon SA
Nippon Shinyaku Co Ltd
Pfizer Inc
Sarepta Therapeutics Inc
WAVE Life Sciences Ltd
Segment by Type
DS-5141
Biostrophin
BMBD-001
NS-065
Others
Segment by Application
Genetic Disorders
Musculoskeletal Disorders
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Dystrophin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Dystrophin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Dystrophin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Dystrophin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Dystrophin introduction, etc. Dystrophin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Dystrophin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.